<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
MEdia Clips

CU Anschutz In The News

Washington Post

Pat yourself on the back, America. Your cholesterol levels are holding steady, CDC says.

news outletWashington Post
Publish DateOctober 25, 2017

Without more data, it’s difficult to pin that HDL improvement on a single factor, said Robert Eckel, a professor of medicine at the University of Colorado and a former president of the American Heart Association. “It can’t be because we’re losing weight, because that’s still going up, but it could be statin use. It could be a result of the decline in smoking. Or a combination of factors,” Eckel said. “Regardless, the message here is a good one. And it reflects other things we’re seeing, like the number of heart attacks which have gone down, too.

Full Story

The doctor of the future

news outletPolitico
Publish DateOctober 25, 2017

It’s no longer true “that you’re a sole cowboy out there, saving the patient on your own,” says Mark Earnest, head of internal medicine at the University of Colorado medical school.

Full Story

How on Earth

news outletKGNU
Publish DateOctober 24, 2017

CU Anschutz professor David Pollock talks about his latest theory of molecular evolution

Full Story
Colorado Politics

Colorado’s work on Down syndrome research headed to D.C.

news outletColorado Politics
Publish DateOctober 20, 2017

On a five-member panel of experts, three are from Colorado: Michelle Sie Whitten, founder, CEO and president of the Global Down Syndrome Foundation, and Frank Stephens, the Quincy Jones Advocate for the Denver-based foundation, who lives in the Washington, D.C., area, as well as Dr. Joaquin M. Espinosa. executive director of the Linda Crnic Institute for Down Syndrome at the University of Colorado School of Medicine. 

Full Story

Some mothers may not seek early help for kids with developmental delays

news outletWHTC
Publish DateOctober 16, 2017

“In the United States, one in four children under the age of 5 years is at moderate to high risk of developmental delay, a situation in which children do not achieve motor, language, cognitive, social or adaptive skills when they should,” said lead study author Dawn Magnusson of the University of Colorado Anschutz Medical Campus in Aurora. “Many mothers in our study experienced challenges accessing early intervention services due to logistical challenges or competing social and financial stressors that resulted in delayed or forgone care,” Magnusson said by email.

Full Story
Washington Post

Does breast-feeding really decrease my cancer risk?

news outletWashington Post
Publish DateOctober 15, 2017

Nursing has been linked to a reduced risk of breast cancer risk in both pre- and post-menopausal women. But, says Virginia Borges, director of the University of Colorado Cancer Center’s young women’s breast cancer program, “it gets complicated from here.” Nursing a baby changes the structure of the breast. Even after breast-feeding ends, microscopic changes in the milk-delivery system protect the breast against precancerous cells, Borges says. This effect is more common among women who have nursed more children or for longer periods than others.

Full Story

Contaminated floodwaters following hurricanes can cause life-threatening skin infections

news outletAccuWeather
Publish DateOctober 06, 2017

“In these flood situations, there’s all that brackish water contaminated with sewage, and water, human waste, and animal filth and other things being a kind of culture broth for bacteria,” said Dr. Whitney High, the director of dermatopathology at the University of Colorado School of Medicine.

Full Story

Insurers are slow to approve pricey new cholesterol drugs

news outletReuters
Publish DateOctober 04, 2017

Dr. Robert Eckel, professor of medicine at the University of Colorado School of Medicine in Denver and former president of the American Heart Association, told Reuters Health that when he prescribes PCSK9 inhibitors, he often hears back from an insurance company with an approval within half an hour. “I know the indications of the drug, how to assess its risk and when I need to push hard,” he said. “I often also explain to my patients upfront that I’m the prescribing physician and not in a position to discuss copays.”

Full Story